| Title |
Trypanocidal drugs for late‐stage, symptomatic Chagas disease (<i>Trypanosoma cruzi</i> infection)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2020
|
| DOI | 10.1002/14651858.cd004102.pub3 |
| Pubmed ID | |
| Authors |
Maite Vallejo, Pedro Pa Reyes, Mireya Martinez Garcia, Alejandro G Gonzalez Garay |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 5 | 33% |
| Mexico | 2 | 13% |
| Chile | 1 | 7% |
| United Kingdom | 1 | 7% |
| New Zealand | 1 | 7% |
| Unknown | 5 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Scientists | 3 | 20% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Germany | 1 | <1% |
| Argentina | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 183 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 31 | 16% |
| Student > Bachelor | 23 | 12% |
| Researcher | 17 | 9% |
| Other | 11 | 6% |
| Student > Ph. D. Student | 11 | 6% |
| Other | 29 | 15% |
| Unknown | 66 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 55 | 29% |
| Nursing and Health Professions | 7 | 4% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Agricultural and Biological Sciences | 6 | 3% |
| Immunology and Microbiology | 6 | 3% |
| Other | 34 | 18% |
| Unknown | 73 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2024.
All research outputs
#4,228,149
of 25,712,965 outputs
Outputs from Cochrane database of systematic reviews
#6,679
of 13,134 outputs
Outputs of similar age
#106,398
of 528,489 outputs
Outputs of similar age from Cochrane database of systematic reviews
#106
of 180 outputs
Altmetric has tracked 25,712,965 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 180 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.